Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Talbot

Showing results (431-440 of 576) with videos related to

Pageof 58
Sort By:
Alimentary Pharmacology & Therapeutics|October 23, 2002
Gut mucosal response to food antigens in Crohn's diseaseJ Van Den Bogaerde, J Cahill, A V Emmanuel, et al.
World Neurosurgery|March 29, 2024
1-Piece Versus 2-Piece Fronto-Temporo-Orbito-Zygomatic Craniotomy: A Narrative Overview of EvolutionMichael S Folse, Elizabeth Jee, Norris C Talbot, et al.
Lung Cancer (Amsterdam, Netherlands)|July 23, 2003
Phase II study of exatecan mesylate (DX-8951f) as first line therapy for advanced non-small cell lung cancerJ P Braybrooke, M Ranson, C Manegold, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cellsA M Abbasi, K A Chester, I C Talbot, et al.
Archives of Disease in Childhood|December 1, 1982
Liver disease in IndiaS A Bhave, A N Pandit, A M Pradhan, et al.
Gut|May 16, 2002
The spectrum of p53 mutations in colorectal adenomas differs from that in colorectal carcinomasX P Hao, I M Frayling, J G Sgouros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatinI E Smith, M E O'Brien, D C Talbot, et al.
British Journal of Cancer|March 10, 2011
Phase II study of single agent capecitabine in the treatment of metastatic non-pancreatic neuroendocrine tumoursL Medley, A N Morel, D Farrugia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Pharmacokinetic study of cisplatin and infusional etoposide phosphate in advanced breast cancer with correlation of response to topoisomerase IIalpha expressionJeremy P Braybrooke, Nicola C Levitt, Simon Joel, et al.
British Journal of Cancer|January 1, 1997
Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancerM I Koukourakis, A Giatromanolaki, K J O'Byrne, et al.
Pageof 58

Showing results (431-440 of 576) with videos related to

Sort By:
Pageof 58
Alimentary Pharmacology & Therapeutics|October 23, 2002
Gut mucosal response to food antigens in Crohn's diseaseJ Van Den Bogaerde, J Cahill, A V Emmanuel, et al.
World Neurosurgery|March 29, 2024
1-Piece Versus 2-Piece Fronto-Temporo-Orbito-Zygomatic Craniotomy: A Narrative Overview of EvolutionMichael S Folse, Elizabeth Jee, Norris C Talbot, et al.
Lung Cancer (Amsterdam, Netherlands)|July 23, 2003
Phase II study of exatecan mesylate (DX-8951f) as first line therapy for advanced non-small cell lung cancerJ P Braybrooke, M Ranson, C Manegold, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cellsA M Abbasi, K A Chester, I C Talbot, et al.
Archives of Disease in Childhood|December 1, 1982
Liver disease in IndiaS A Bhave, A N Pandit, A M Pradhan, et al.
Gut|May 16, 2002
The spectrum of p53 mutations in colorectal adenomas differs from that in colorectal carcinomasX P Hao, I M Frayling, J G Sgouros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatinI E Smith, M E O'Brien, D C Talbot, et al.
British Journal of Cancer|March 10, 2011
Phase II study of single agent capecitabine in the treatment of metastatic non-pancreatic neuroendocrine tumoursL Medley, A N Morel, D Farrugia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Pharmacokinetic study of cisplatin and infusional etoposide phosphate in advanced breast cancer with correlation of response to topoisomerase IIalpha expressionJeremy P Braybrooke, Nicola C Levitt, Simon Joel, et al.
British Journal of Cancer|January 1, 1997
Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancerM I Koukourakis, A Giatromanolaki, K J O'Byrne, et al.
Pageof 58